Atlas Trials

Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy

Clinical trial NCT00694603 · TERMINATED

Trial details

NCT number
NCT00694603
Sponsor
Lecia V. Sequist
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2006-09-01
Primary completion
2009-09-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.